171 related articles for article (PubMed ID: 26934454)
1. Effectiveness of tacrolimus in comparison with methotrexate or biologics in propensity score-matched patients with rheumatoid arthritis.
Nakajima A; Inoue E; Taniguchi A; Momohara S; Yamanaka H
Mod Rheumatol; 2016 Nov; 26(6):836-843. PubMed ID: 26934454
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of adjunct tacrolimus treatment in patients with rheumatoid arthritis with inadequate responses to methotrexate.
Kitahama M; Nakajima A; Inoue E; Taniguchi A; Momohara S; Yamanaka H
Mod Rheumatol; 2013 Jul; 23(4):788-93. PubMed ID: 22975732
[TBL] [Abstract][Full Text] [Related]
3. Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use.
Takahashi N; Fujibayashi T; Kida D; Hirano Y; Kato T; Kato D; Saito K; Kaneko A; Yabe Y; Takagi H; Oguchi T; Miyake H; Watanabe T; Hayashi M; Kanayama Y; Funahashi K; Hanabayashi M; Hirabara S; Asai S; Takemoto T; Terabe K; Asai N; Yoshioka Y; Ishiguro N; Kojima T
Rheumatol Int; 2015 Oct; 35(10):1707-16. PubMed ID: 25991396
[TBL] [Abstract][Full Text] [Related]
4. Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis.
Bergstra SA; Allaart CF; van den Berg R; Chopra A; Govind N; Huizinga TWJ; Landewe RBM
Arthritis Res Ther; 2017 Nov; 19(1):258. PubMed ID: 29166919
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of add-on tacrolimus versus leflunomide in rheumatoid arthritis patients with inadequate response to methotrexate.
Shin K; Baek HJ; Kang YM; Cha HS; Kang SW; Park SH; Jun JB; Lee YJ; Choi IA; Song YW
Int J Rheum Dis; 2019 Jun; 22(6):1115-1122. PubMed ID: 30861334
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.
Müller RB; von Kempis J; Haile SR; Schiff MH
Semin Arthritis Rheum; 2015 Aug; 45(1):28-34. PubMed ID: 25895697
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of radiographic joint damage in rheumatoid arthritis patients in DAS28 remission using single- or combined with methotrexate non biological disease-modifying antirheumatic drug therapy in routine clinical practice.
Katayama K; Okubo T; Sato T; Ito H; Fukai R; Baba H
Mod Rheumatol; 2015 Jan; 25(1):50-5. PubMed ID: 24983407
[TBL] [Abstract][Full Text] [Related]
8. Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus.
Migita K; Akeda Y; Akazawa M; Tohma S; Hirano F; Ideguchi H; Matsumura R; Suematsu E; Miyamura T; Mori S; Fukui T; Izumi Y; Iwanaga N; Tsutani H; Saisyo K; Yamanaka T; Ohshima S; Sugiyama T; Kawabe Y; Katayama M; Suenaga Y; Okamoto A; Ohshima H; Okada Y; Ichikawa K; Yoshizawa S; Kawakami K; Matsui T; Furukawa H; Oishi K
Arthritis Res Ther; 2015 Jun; 17(1):149. PubMed ID: 26036592
[TBL] [Abstract][Full Text] [Related]
9. Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.
Sauer BC; Teng CC; Tang D; Leng J; Curtis JR; Mikuls TR; Harrison DJ; Cannon GW
Arthritis Care Res (Hoboken); 2017 Mar; 69(3):313-322. PubMed ID: 27273801
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy and safety of add-on tacrolimus for persistent, active rheumatoid arthritis despite treatment with methotrexate and tumor necrosis factor inhibitors.
Naniwa T; Iwagaitsu S; Kajiura M
Int J Rheum Dis; 2018 Mar; 21(3):673-687. PubMed ID: 29314738
[TBL] [Abstract][Full Text] [Related]
11. Effect of additional administration of tacrolimus in patients with rheumatoid arthritis treated with biologics.
Miyata M; Asano T; Satoh S
Fukushima J Med Sci; 2011; 57(2):54-9. PubMed ID: 22353651
[TBL] [Abstract][Full Text] [Related]
12. Long-term therapeutic effects and safety of tacrolimus added to methotrexate in patients with rheumatoid arthritis.
Kanzaki T; Kawahata K; Kanda H; Fujio K; Kubo K; Akahira L; Michishita K; Eri T; Yamamoto K
Rheumatol Int; 2013 Apr; 33(4):871-7. PubMed ID: 22806421
[TBL] [Abstract][Full Text] [Related]
13. Comparison of efficacy and safety of tacrolimus and methotrexate in combination with abatacept in patients with rheumatoid arthritis; a retrospective observational study in the TBC Registry.
Fujibayashi T; Takahashi N; Kida D; Kaneko A; Hirano Y; Fukaya N; Yabe Y; Oguchi T; Tsuboi S; Miyake H; Takemoto T; Kawasaki M; Ishiguro N; Kojima T
Mod Rheumatol; 2015; 25(6):825-30. PubMed ID: 25775147
[TBL] [Abstract][Full Text] [Related]
14. Midterm clinico-radiologic findings of an open label observation study of add-on tacrolimus with biologics or non-biologic DMARDs.
Takakubo Y; Tamaki Y; Hirayama T; Iwazaki K; Yang S; Sasaki A; Nakano H; Konttinen YT; Takagi M
Rheumatol Int; 2012 Nov; 32(11):3487-94. PubMed ID: 22065071
[TBL] [Abstract][Full Text] [Related]
15. When to adjust therapy in patients with rheumatoid arthritis after initiation of etanercept plus methotrexate or methotrexate alone: findings from a randomized study (COMET).
Dougados MR; van der Heijde DM; Brault Y; Koenig AS; Logeart IS
J Rheumatol; 2014 Oct; 41(10):1922-34. PubMed ID: 25128520
[TBL] [Abstract][Full Text] [Related]
16. Triple Oral Therapy Versus Antitumor Necrosis Factor Plus Methotrexate (MTX) in Patients with Rheumatoid Arthritis and Inadequate Response to MTX: A Systematic Literature Review.
Mary J; De Bandt M; Lukas C; Morel J; Combe B
J Rheumatol; 2017 Jun; 44(6):773-779. PubMed ID: 28412710
[TBL] [Abstract][Full Text] [Related]
17. Prediction of DAS28-CRP remission in patients with rheumatoid arthritis treated with tacrolimus at 6 months by baseline variables.
Aramaki T; Kawakami A; Iwamoto N; Fujikawa K; Kawashiri SY; Tamai M; Arima K; Kamachi M; Yamasaki S; Nakamura H; Nakashima M; Mizokami A; Furuyama M; Matsuoka N; Ueki Y; Ida H; Origuchi T; Aoyagi K; Eguchi K
Mod Rheumatol; 2009; 19(6):652-6. PubMed ID: 19787419
[TBL] [Abstract][Full Text] [Related]
18. Utilization of Subcutaneous Methotrexate in Rheumatoid Arthritis Patients After Failure or Intolerance to Oral Methotrexate: A Multicenter Cohort Study.
Branco JC; Barcelos A; de Araújo FP; Sequeira G; Cunha I; Patto JV; Oliveira M; Mateus MP; Couto M; Nero P; Pinto P; Monteiro P; Castelão W; Félix J; Ferreira D; Almeida J; Silva MJ
Adv Ther; 2016 Jan; 33(1):46-57. PubMed ID: 26724937
[TBL] [Abstract][Full Text] [Related]
19. Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study.
Kojima T; Yabe Y; Kaneko A; Takahashi N; Funahashi K; Kato D; Hanabayashi M; Asai S; Hirabara S; Asai N; Hirano Y; Hayashi M; Miyake H; Kojima M; Ishiguro N
Rheumatology (Oxford); 2015 Jan; 54(1):113-20. PubMed ID: 25102861
[TBL] [Abstract][Full Text] [Related]
20. How to treat patients with rheumatoid arthritis when methotrexate has failed? The use of a multiple propensity score to adjust for confounding by indication in observational studies.
Bergstra SA; Winchow LL; Murphy E; Chopra A; Salomon-Escoto K; Fonseca JE; Allaart CF; Landewé RBM
Ann Rheum Dis; 2019 Jan; 78(1):25-30. PubMed ID: 30327328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
